COMPOSITIONS COMPRISING ANTI-CEACAM1 AND ANTI-PD ANTIBODIES FOR CANCER THERAPY
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides compositions comprising anti-CEACAM1 antibodies, compositions comprising antibodies capable of inhibiting or blocking the interaction between PD-1 and its ligands, and methods for their combined use in treating cancer.
-
Citations
68 Claims
-
1-50. -50. (canceled)
-
51. A composition comprising:
-
a pharmaceutical composition comprising a monoclonal antibody to human CEACAM1 or an antigen-binding fragment thereof; and a pharmaceutical composition comprising a monoclonal antibody to at least one of human PD-1, PD-L1 and PD-L2 or an antigen-binding fragment thereof wherein said pharmaceutical compositions are in separate containers.
-
-
60. A method for treating a patient having cancer, comprising the steps of separately administering to said patient:
-
(i) a pharmaceutical composition comprising a monoclonal antibody to human CEACAM1 or an antigen-binding fragment thereof; and (ii) a pharmaceutical composition comprising a monoclonal antibody to at least one of human PD-1, PD-L1 and PD-L2 or an antigen-binding fragment thereof; thereby treating said cancer.
-
-
68. A kit comprising:
-
(i) a pharmaceutical composition comprising a monoclonal antibody to human CEACAM1 or an antigen-binding fragment thereof; and (ii) a pharmaceutical composition comprising a monoclonal antibody to at least one of human PD-1, PD-L1 and PD-L2 or an antigen-binding fragment thereof.
-
Specification